These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability. Portek I; Graham G; Fleming A Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303 [TBL] [Abstract][Full Text] [Related]
6. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations. Armstrong BK; Ukich AW; Goatcher PM Med J Aust; 1970 Jul; 2(4):181-3. PubMed ID: 4917130 [No Abstract] [Full Text] [Related]
7. The bioavailability of enteric-coated acetylsalicylic acid: a comparison with buffered ASA in rheumatoid arthritis II. Canada AT; Little AH; Creighton EL Curr Ther Res Clin Exp; 1976 May; 19(5):554-7. PubMed ID: 820521 [No Abstract] [Full Text] [Related]
8. Plasma salicylate concentrations following chronic administration of aspirin as conventional and sustained-release tablets. Wiseman EH Curr Ther Res Clin Exp; 1969 Nov; 11(11):681-9. PubMed ID: 4982303 [No Abstract] [Full Text] [Related]
9. Comparative bioavailability of sustained-release and uncoated aspirin tablets. Karahalios WJ; Sawyer WT; Rittase RA; Maynard SA Am J Hosp Pharm; 1981 Nov; 38(11):1754-6. PubMed ID: 7304632 [TBL] [Abstract][Full Text] [Related]
10. Serum salicylate concentrations and endoscopic evaluation of the gastric mucosa in dogs after oral administration of aspirin-containing products. Lipowitz AJ; Boulay JP; Klausner JS Am J Vet Res; 1986 Jul; 47(7):1586-9. PubMed ID: 3740630 [TBL] [Abstract][Full Text] [Related]
11. [Enteric aspirin tablets and the salicylate concentration in the plasma in the morning]. Laine V; Strandman D; Tikkanen R Lakartidningen; 1968 Sep; 65(39):3832-7 passim. PubMed ID: 5741894 [No Abstract] [Full Text] [Related]
12. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level]. Nap RC; Breen DJ; Lam TJ; Peters IO; Willemsen A; De Bruyne JJ Tijdschr Diergeneeskd; 1993 Jul; 118(13):439-42. PubMed ID: 8346511 [TBL] [Abstract][Full Text] [Related]
13. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets. Paton TW; Walker SE; Leung FY; Little AH Clin Pharm; 1983; 2(2):165-6. PubMed ID: 6883946 [No Abstract] [Full Text] [Related]
14. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations. Schwertner HA; McGlasson D; Christopher M; Bush AC Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420 [TBL] [Abstract][Full Text] [Related]
15. Interaction of omeprazole with enteric-coated salicylate tablets. Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060 [TBL] [Abstract][Full Text] [Related]
16. [In vivo drug release from microencapsulated acetylsalicylic acid with simultaneous alcohol uptake]. Frömming KH; Schwabe L Arzneimittelforschung; 1980; 30(5):836-9. PubMed ID: 7190431 [TBL] [Abstract][Full Text] [Related]
17. A comparison of enteric-coated aspirin granules with plain and buffered aspirin: a report of two studies. Petroski D Am J Gastroenterol; 1986 Jan; 81(1):26-8. PubMed ID: 3942122 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of an enteric coated aspirin preparation. Day RO; Paull PD; Champion GD; Graham GG Aust N Z J Med; 1976 Feb; 6(1):45-50. PubMed ID: 1065299 [TBL] [Abstract][Full Text] [Related]
19. Metabolism of salicylate during chronic aspirin therapy. Rumble RH; Brooks PM; Roberts MS Br J Clin Pharmacol; 1980 Jan; 9(1):41-5. PubMed ID: 7356892 [TBL] [Abstract][Full Text] [Related]
20. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss. Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG Aust N Z J Med; 1977 Dec; 7(6):600-4. PubMed ID: 350214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]